Cardinal Manufacturing Operations Are Primary Focus Of Restructuring
This article was originally published in The Gray Sheet
Executive Summary
The first phase of Cardinal's restructuring plan will have the biggest impact on the company's contract manufacturing operations
You may also be interested in...
Cardinal Appoints Former Alaris CEO To Head New Point-Of-Care Group
Former Alaris Medical Systems President & CEO David Schlotterbeck will oversee Cardinal Health's patient point-of-care strategy as chief of the firm's new Clinical Technology & Services division
European I.V. Presence Lures Cardinal To Acquire Alaris For $2 Bil.
The 18% premium Cardinal Health will pay for Alaris Medical Systems reflects the growing market presence of the I.V. medication safety device manufacturer
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.